iShares US Pharmaceuticals ETF
IHE
IHE
84 hedge funds and large institutions have $157M invested in iShares US Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 36 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $197M → $157M (-$39.6M)
50% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 36
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
84
Holding in Top 10
1
Calls
$608K
Puts
$4K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$2.4M | |
| 3 | +$782K | |
| 4 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$747K |
| 5 |
SG Americas Securities
New York
|
+$356K |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$8.44M | |
| 3 | -$7.5M | |
| 4 |
EAMA
EFG Asset Management (Americas)
Miami,
Florida
|
-$6.43M |
| 5 |
VF
Virtu Financial
New York
|
-$2.79M |